RFG
PFE icon

REAP Financial Group’s Pfizer PFE Stock Holding History

REAP Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150K Sell
6,242
-519
-8% -$13.6K 0.03% 167
2026
Q1 		$190K Sell
6,761
-127
-2% -$3.38K 0.04% 135
2025
Q4 		$172K Buy
6,888
+1,940
+39% +$48.9K 0.03% 143
2025
Q3 		$126K Buy
4,948
+697
+16% +$17.2K 0.03% 158
2025
Q2 		$103K Buy
4,251
+1,804
+74% +$42.1K 0.02% 170
2025
Q1 		$62K Buy
2,447
+1,042
+74% +$27.3K 0.02% 194
2024
Q4 		$37.3K Buy
1,405
+629
+81% +$17.1K 0.01% 232
2024
Q3 		$22.5K Sell
776
-4
-0.5% -$117 0.01% 260
2024
Q2 		$21.8K Sell
780
-66
-8% -$1.82K 0.01% 242
2024
Q1 		$23.5K Sell
846
-3,999
-83% -$111K 0.01% 262
2023
Q4 		$139K Buy
+4,845
New +$146K 0.04% 162

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

REAP Financial Group's PFE Position: Q2 2026 in Review

REAP Financial Group reduced its Pfizer (PFE) stake by 7.7% in Q2 2026, selling an estimated $13.6K and leaving 6,242 shares worth $150K. The position accounts for 0.03% of the portfolio, ranked #167.

REAP Financial Group first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $190K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • REAP Financial Group held 6,242 shares of Pfizer worth $150K as of Q2 2026.
  • REAP Financial Group sold 519 Pfizer shares in Q2 2026, an estimated $13.6K.
  • Pfizer made up 0.03% of REAP Financial Group's portfolio in Q2 2026, its #167 holding.
  • REAP Financial Group first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's Pfizer position peaked at $190K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.